Immunic Selling And Marketing Expenses vs Operating Income Analysis

IMUX Stock  USD 0.95  0  0.32%   
Immunic financial indicator trend analysis is infinitely more than just investigating Immunic recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunic is a good investment. Please check the relationship between Immunic Selling And Marketing Expenses and its Operating Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Selling And Marketing Expenses vs Operating Income

Selling And Marketing Expenses vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunic Selling And Marketing Expenses account and Operating Income. At this time, the significance of the direction appears to have weak relationship.
The correlation between Immunic's Selling And Marketing Expenses and Operating Income is 0.35. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Operating Income in the same time period over historical financial statements of Immunic, assuming nothing else is changed. The correlation between historical values of Immunic's Selling And Marketing Expenses and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Immunic are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Selling And Marketing Expenses i.e., Immunic's Selling And Marketing Expenses and Operating Income go up and down completely randomly.

Correlation Coefficient

0.35
Relationship DirectionPositive 
Relationship StrengthVery Weak

Selling And Marketing Expenses

Operating Income

Operating Income is the amount of profit realized from Immunic operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Immunic is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from Immunic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.Selling General Administrative is likely to drop to about 14 M in 2025. Issuance Of Capital Stock is likely to drop to about 931.9 K in 2025
 2022 2023 2024 2025 (projected)
Net Interest Income1.0M3.1M3.5M3.7M
Interest Income1.0M3.1M3.5M3.7M

Immunic fundamental ratios Correlations

0.240.240.30.970.22-0.95-0.020.550.960.60.960.32-0.610.70.29-0.540.220.97-0.23-0.47-0.510.260.260.330.06
0.240.710.760.16-0.05-0.21-0.640.290.28-0.20.30.84-0.250.380.650.04-0.050.33-0.01-0.03-0.490.620.620.53-0.57
0.240.710.980.220.15-0.2-0.640.460.32-0.220.310.88-0.430.290.7-0.150.150.32-0.15-0.43-0.50.650.660.36-0.61
0.30.760.980.260.04-0.21-0.630.420.33-0.080.320.94-0.430.370.7-0.140.040.34-0.04-0.42-0.570.60.610.36-0.53
0.970.160.220.260.27-0.93-0.070.530.940.570.940.25-0.760.640.33-0.730.270.94-0.14-0.61-0.560.310.310.150.01
0.22-0.050.150.040.27-0.440.070.640.42-0.370.41-0.18-0.34-0.15-0.02-0.331.00.37-0.58-0.310.240.160.160.15-0.1
-0.95-0.21-0.2-0.21-0.93-0.440.0-0.64-0.99-0.4-0.98-0.180.61-0.54-0.230.55-0.44-0.980.350.470.4-0.32-0.32-0.330.01
-0.02-0.64-0.64-0.63-0.070.070.00.06-0.060.26-0.06-0.660.41-0.24-0.950.230.07-0.09-0.160.320.66-0.85-0.860.050.88
0.550.290.460.420.530.64-0.640.060.670.00.650.28-0.450.220.07-0.310.640.63-0.32-0.43-0.220.290.290.34-0.06
0.960.280.320.330.940.42-0.99-0.060.670.380.990.29-0.630.550.32-0.550.420.99-0.34-0.49-0.460.360.360.35-0.07
0.6-0.2-0.22-0.080.57-0.37-0.40.260.00.380.350.02-0.250.55-0.08-0.28-0.370.390.26-0.31-0.39-0.22-0.22-0.050.54
0.960.30.310.320.940.41-0.98-0.060.650.990.350.3-0.620.560.31-0.540.411.0-0.36-0.44-0.440.350.350.38-0.08
0.320.840.880.940.25-0.18-0.18-0.660.280.290.020.3-0.330.510.74-0.05-0.180.340.04-0.25-0.620.560.570.43-0.51
-0.61-0.25-0.43-0.43-0.76-0.340.610.41-0.45-0.63-0.25-0.62-0.33-0.39-0.550.94-0.34-0.62-0.120.870.68-0.57-0.570.170.34
0.70.380.290.370.64-0.15-0.54-0.240.220.550.550.560.51-0.390.41-0.25-0.150.63-0.09-0.26-0.50.320.320.34-0.12
0.290.650.70.70.33-0.02-0.23-0.950.070.32-0.080.310.74-0.550.41-0.37-0.020.340.05-0.44-0.740.840.850.08-0.79
-0.540.04-0.15-0.14-0.73-0.330.550.23-0.31-0.55-0.28-0.54-0.050.94-0.25-0.37-0.33-0.54-0.170.810.53-0.38-0.380.370.19
0.22-0.050.150.040.271.0-0.440.070.640.42-0.370.41-0.18-0.34-0.15-0.02-0.330.37-0.58-0.310.240.160.160.15-0.1
0.970.330.320.340.940.37-0.98-0.090.630.990.391.00.34-0.620.630.34-0.540.37-0.35-0.44-0.460.360.370.39-0.08
-0.23-0.01-0.15-0.04-0.14-0.580.35-0.16-0.32-0.340.26-0.360.04-0.12-0.090.05-0.17-0.58-0.35-0.17-0.420.060.06-0.65-0.04
-0.47-0.03-0.43-0.42-0.61-0.310.470.32-0.43-0.49-0.31-0.44-0.250.87-0.26-0.440.81-0.31-0.44-0.170.6-0.46-0.470.260.21
-0.51-0.49-0.5-0.57-0.560.240.40.66-0.22-0.46-0.39-0.44-0.620.68-0.5-0.740.530.24-0.46-0.420.6-0.7-0.70.180.48
0.260.620.650.60.310.16-0.32-0.850.290.36-0.220.350.56-0.570.320.84-0.380.160.360.06-0.46-0.71.0-0.01-0.88
0.260.620.660.610.310.16-0.32-0.860.290.36-0.220.350.57-0.570.320.85-0.380.160.370.06-0.47-0.71.0-0.01-0.88
0.330.530.360.360.150.15-0.330.050.340.35-0.050.380.430.170.340.080.370.150.39-0.650.260.18-0.01-0.010.07
0.06-0.57-0.61-0.530.01-0.10.010.88-0.06-0.070.54-0.08-0.510.34-0.12-0.790.19-0.1-0.08-0.040.210.48-0.88-0.880.07
Click cells to compare fundamentals

Immunic Account Relationship Matchups

Immunic fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets167.9M139.1M127.8M54.3M62.4M81.3M
Short Long Term Debt Total679K584K1.6M1.3M1.5M955.9K
Other Current Liab4.4M7.2M8.2M18.9M21.8M22.9M
Total Current Liabilities8.4M11.4M13.1M24.7M28.4M29.9M
Total Stockholder Equity158.8M127.1M113.7M28.9M33.3M64.9M
Property Plant And Equipment Net1.1M1.1M1.8M1.8M1.6M1.4M
Net Debt(126.8M)(86.3M)(105.2M)(45.3M)(40.8M)(42.8M)
Retained Earnings(103.9M)(196.9M)(317.3M)(410.9M)(369.8M)(351.3M)
Accounts Payable3.7M3.7M4.3M5.1M5.9M3.9M
Cash127.5M86.9M106.7M46.7M53.7M64.0M
Non Current Assets Total34.1M34.1M1.9M1.8M2.0M1.9M
Cash And Short Term Investments127.5M86.9M116.4M46.7M53.7M66.0M
Common Stock Shares Outstanding15.7M23.7M31.8M44.3M51.0M53.5M
Liabilities And Stockholders Equity167.9M139.1M127.8M54.3M62.4M81.3M
Non Current Liabilities Total679K584K992K639K575.1K546.3K
Other Current Assets6.3M18.1M9.5M5.2M5.9M4.6M
Other Stockholder Equity266.8M324.2M427.9M436.1M501.5M526.5M
Total Liab9.1M12.0M14.1M25.4M22.8M11.9M
Property Plant And Equipment Gross1.1M1.1M1.8M1.8M1.6M1.4M
Total Current Assets133.7M105.0M125.9M52.5M60.4M70.8M
Accumulated Other Comprehensive Income(4.1M)(252K)3.0M3.8M4.3M4.5M
Short Term Debt297K408K571K695K799.3K797.9K
Net Tangible Assets25.4M125.8M94.1M113.7M130.7M80.6M
Retained Earnings Total Equity(59.9M)(103.9M)(196.9M)(317.3M)(285.6M)(299.8M)
Capital Surpluse119.6M266.8M324.2M427.9M492.1M326.3M
Non Current Liabilities Other520K679K584K992K1.1M1.2M
Property Plant Equipment80K203K1.1M294K264.6K251.4K
Other Assets37K42K943K43K49.5K47.0K
Net Receivables1.6M2.2M2.7M703K808.5K1.3M
Net Invested Capital158.8M127.1M113.7M28.9M33.3M31.6M
Net Working Capital125.3M93.6M112.8M27.8M32.0M30.4M
Capital Lease Obligations679K584K1.6M1.3M1.5M1.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.